BioCentury
ARTICLE | Strategy

Bug battle plan

GSK hoping a government funded unit will battle infectious diseases threats

August 1, 2016 7:00 AM UTC

Tired of waiting for the international community to organize proactive responses to the threats posed by emerging infectious diseases, GlaxoSmithKline plc has developed plans and is soliciting government support to create a permanent, independent entity dedicated to developing vaccines to protect against pathogens that could become mass killers.

The concept was created as a result of GSK's frustrations over flaws in responses to the pandemic influenza and Ebola outbreaks. And more recent events have further dramatized the importance of acting on the longstanding need to conduct sustained vaccine R&D targeting infectious pathogens that could create public health disasters. ...